Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity

• Published in: Obesity surgery 2004-04, Vol.14 (4), p.509-513
• Main Authors: Raftopoulos, Yannis, Gagné, Daniel J, Papasavas, Pavlos, Hayetian, Fernando, Maurer, Julie, Bononi, Patricia, Caushaj, Philip F
• Format: Article
• Language: English
• Subjects: Adult; Aged; Anastomosis, Roux-en-Y; Body Mass Index; Comorbidity; Female; Gastric Bypass; Gastrointestinal surgery; Humans; Hypothyroidism; Hypothyroidism - drug therapy; Hypothyroidism - epidemiology; Male; Middle Aged; Obesity, Morbid - epidemiology; Obesity, Morbid - surgery; Thyroid gland; Thyroxine - administration & dosage
• ISSN: 0960-8923; 1708-0428
• DOI: 10.1381/096089204323013514

Laparoscopic Roux-en-Y gastric bypass (LRYGBP) has been very effective in managing a broad range of morbid obesity-related co-morbidities. We report a beneficial effect of LRYGBP that has not been previously observed. Between December 1999 and September 2002, 224 patients underwent LRYGBP. Preoperative assessment for hypothyroidism and follow-up data were prospectively collected in our database. Improved thyroid function (ITF) or unchanged thyroid function (UTF) was determined by comparison of preoperative and postoperative thyroxine requirements. 23 of 224 patients (10.3%) were treated preoperatively for hypothyroidism. During a median follow-up of 17 months, hypothyroidism was improved in 10/23 patients (43.5%). 2 patients had complete resolution, and the remaining 8 had reduction (14%-50%) of their thyroxine requirements. ITF occurred at a mean follow-up of 8.9 months and at a mean excess weight loss (EWL) of 57%. 6 of the 8 patients (75%) with ITF >or= 25% had EWL >90% at last follow-up, compared to 1 out of 15 patients (6.6%) with UTF or